Top Markets
Coin of the day
Xvivo Perfusion AB (publ) Xvivo Perfusion AB (publ)

Xvivo Perfusion AB (publ)

XVIVO
Rank in Stocks #9727
Xvivo Perfusion AB (publ) is a medical technology company that creates and... Xvivo Perfusion AB (publ) is a medical technology company that creates and supplies advanced solutions for the preservation and perfusion of organs, tissues, and cells, primarily for use in transplantation. The company's global reach extends across Sweden, the United States, both North and South America, Europe, the Middle East, Africa, and the Asia Pacific region. Its product line includes the XVIVO System (XPS), an integrated, ready-to-use cardiac bypass system designed to facilitate safe normothermic ex vivo lung perfusion (EVLP). To support this, the XPS Disposable Lung Kit offers all the necessary sterile, pre-packed components for EVLP procedures. Xvivo also provides STEEN Solution, an optimally formulated buffered extracellular solution specifically for perfusing isolated donor lungs during EVLP. Additional offerings comprise Perfadex Plus, an extracellular, low-potassium, dextran-based electrolyte preservation solution, and the XVIVO Silicone Tubing Set, used for efficient flushing of donor lungs during the procurement process. The company also manufactures the XVIVO LS and XVIVO Disposable Lung Set, both critical devices for EVLP. Furthermore, Xvivo provides the XVIVO Organ Chamber, a sterile, single-use disposable container for temporarily housing isolated lungs before transplantation, and the XVIVO Lung Cannula Set, another sterile, single-use disposable medical product. Established in 1998, Xvivo Perfusion AB (publ) is headquartered in Gothenburg, Sweden.
Share Price
$30.43
Last synced: 2026-08-28
Market Cap
$958.38M
Change (1 day)
-3.95%
Change (1 year)
71.66%
Country
SE
Trade Xvivo Perfusion AB (publ) (XVIVO)

Category

Price of XVIVO with the market cap of B
Xvivo Perfusion AB (publ) Xvivo Perfusion AB (publ)
XVIVO
$30.43
Market Capitalization of Xvivo Perfusion AB (publ)(XVIVO)
Market Cap: $958.38M
As of August 2026 Xvivo Perfusion AB (publ) has a market cap of $958.38M. This makes Xvivo Perfusion AB (publ) the world's 9727th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Xvivo Perfusion AB (publ) from 2012 to 2026
XVIVO compared with Top 5 Most Popular stocks
Price of XVIVO Asset B Mkt. of B Results
Xvivo Perfusion AB (publ) Xvivo Perfusion AB (publ)
$167,110 $958.38M
$5.264T +549,145.58%
Xvivo Perfusion AB (publ) Xvivo Perfusion AB (publ)
$149,249 $958.38M
$4.701T +490,443.29%
Xvivo Perfusion AB (publ) Xvivo Perfusion AB (publ)
$132,611 $958.38M
$4.177T +435,757.53%
Xvivo Perfusion AB (publ) Xvivo Perfusion AB (publ)
$121,189 $958.38M
$3.817T +398,217.51%
Xvivo Perfusion AB (publ) Xvivo Perfusion AB (publ)
$90,996.35 $958.38M
$2.866T +298,981.00%